SCHEMBL3847280

SCHEMBL3847280

Fc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)C3C=CC=CC3)cc2-c2cc(Cl)c3ncc(-c4ccccn4)n3c2)cc1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.31
AKT2 P31751 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846073 0.88 KDR (0.31)
SCHEMBL3846336 0.88 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL3847482 0.88 TGFBR1 (0.34) AKT1AKT2
SCHEMBL3847277 0.84 SMN1; SMN2 (0.36) AKT1AKT2SMN1; SMN2
SCHEMBL3850115 0.83 SMN1; SMN2 (0.32) SMN1; SMN2
SCHEMBL3847545 0.83 MET (0.33)
SCHEMBL3847950 0.81 KDR (0.32)
SCHEMBL3848181 0.81 FLT3 (0.39) AKT1AKT2
SCHEMBL3845238 0.80
SCHEMBL3847290 0.80 TGFBR1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed